no weight loss 2 weeks semaglutide 50 mg of oral #semaglutide daily was associated with body reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type #diabetes. https://ja.ma/41sPiYj Semaglutide | Regenerative Medicine Center

Conversely, under conditions of nutrient excess, GIP signaling may facilitate hepatic lipid uptake and contribute to steatosis, suggesting that the net hepatic outcome reflects a balance between GIP agonism and antagonism [79]

Why Choose Centre for Surgery for Your Liposuction Recovery

Schlabritz-Loutsevitch N et al

In March 2026, the first phase III clinical study (HS-20094-301) of olepotide in overweight or obese adult subjects in China achieved its primary endpoint

ALSO SEE: DOM Monthly Research Meetings launch with focus on cardiovascular disease | Posted April 3, 2026 Metabolic health focus of latest SOAR in DOM Forum | Feb